Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $982.24 million. The enterprise value is $425.98 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 115.83 million shares outstanding. The number of shares has increased by 9.22% in one year.
| Current Share Class | 115.83M |
| Shares Outstanding | 115.83M |
| Shares Change (YoY) | +9.22% |
| Shares Change (QoQ) | +6.22% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 85.77% |
| Float | 110.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.46 |
| Forward PS | 18.66 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.21, with a Debt / Equity ratio of 0.13.
| Current Ratio | 6.21 |
| Quick Ratio | 5.57 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.11% and return on invested capital (ROIC) is -31.32%.
| Return on Equity (ROE) | -52.11% |
| Return on Assets (ROA) | -28.51% |
| Return on Invested Capital (ROIC) | -31.32% |
| Return on Capital Employed (ROCE) | -57.57% |
| Revenue Per Employee | $142,749 |
| Profits Per Employee | -$1.11M |
| Employee Count | 403 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.30% in the last 52 weeks. The beta is 2.11, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 2.11 |
| 52-Week Price Change | -39.30% |
| 50-Day Moving Average | 16.83 |
| 200-Day Moving Average | 11.49 |
| Relative Strength Index (RSI) | 30.02 |
| Average Volume (20 Days) | 11,779,834 |
Short Selling Information
The latest short interest is 39.08 million, so 33.74% of the outstanding shares have been sold short.
| Short Interest | 39.08M |
| Short Previous Month | 30.90M |
| Short % of Shares Out | 33.74% |
| Short % of Float | 35.39% |
| Short Ratio (days to cover) | 4.00 |
Income Statement
In the last 12 months, NTLA had revenue of $57.53 million and -$445.81 million in losses. Loss per share was -$4.25.
| Revenue | 57.53M |
| Gross Profit | -352.35M |
| Operating Income | -478.73M |
| Pretax Income | -445.81M |
| Net Income | -445.81M |
| EBITDA | -466.25M |
| EBIT | -478.73M |
| Loss Per Share | -$4.25 |
Full Income StatementBalance Sheet
The company has $511.04 million in cash and $97.97 million in debt, giving a net cash position of $571.89 million or $4.94 per share.
| Cash & Cash Equivalents | 511.04M |
| Total Debt | 97.97M |
| Net Cash | 571.89M |
| Net Cash Per Share | $4.94 |
| Equity (Book Value) | 748.42M |
| Book Value Per Share | 6.46 |
| Working Capital | 488.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$410.65 million and capital expenditures -$1.98 million, giving a free cash flow of -$412.63 million.
| Operating Cash Flow | -410.65M |
| Capital Expenditures | -1.98M |
| Free Cash Flow | -412.63M |
| FCF Per Share | -$3.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -832.16% |
| Pretax Margin | -774.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.22% |
| Shareholder Yield | -9.22% |
| Earnings Yield | -44.68% |
| FCF Yield | -41.35% |
Dividend DetailsAnalyst Forecast
The average price target for NTLA is $19.83, which is 133.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.83 |
| Price Target Difference | 133.84% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 104.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of -0.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.72 |
| Piotroski F-Score | 3 |
